Efficacy of Traditional Chinese Medicines in Preventing Oxaliplatin-induced Peripheral Neurotoxicity in Cancer Patients:A Network Meta-analysis

被引:0
|
作者
Xiao-chen Wei [1 ]
Li-qin Zhu [1 ]
Hui Wang [2 ]
Chun-ge Wang [1 ]
Qi Deng [1 ]
Xin Li [1 ]
机构
[1] Tianjin First Central Hospital
[2] Tianjin Fourth Hospital
关键词
network meta-analysis; oxaliplatin; peripheral neurotoxicity; prevention; traditional Chinese medicines;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
摘要
Objective Oxaliplatin-induced peripheral neurotoxicity(OIPN) is the main limitation for its continuation in cancer patients.Traditional Chinese medicines(TCMs) have been used to prevent OIPN in China and have been demonstrated to be effective.However,due to the lack of direct comparison among TCMs,it remains unclear that which TCM is the best for OIPN prevention.Consequently,the present study aimed to compare the relative efficacies of TCMs to find out the best TCM by applying a network meta-analysis.Methods Studies were identified by searching PubMed,EMbase,Cochrane Libraries,CNKI,WanFang,and WeiPu database from January 1990 to May2016.Randomized controlled trials(RCTs) that evaluated the efficacy of TCMs in preventing OIPN in cancer patients were included.Statistical analysis was performed with ADDIS 1.1 6.6.Results Twenty-five RCTs(1572 patients) involving five TCMs were included.The results of network meta-analyses showed that compared with oxaliplatin-based chemotherapy alone,the combination with Huangqi Injection(HQI),Shenmai Injection(SMI),Shenfu Injection(SFI),Buyang Huanwu Decoction(BHD),and Huangqi Guizhi Wuwu Decoction(HGWD) could decrease the overall OIPN incidence and the severe OIPN incidence in cancer patients.In addition,probability ranking results showed the order of efficacy in preventing overall OIPN incidence was HQI > HGWD > SFI =SMI > BHD,while the order of efficacy in preventing severe OIPN incidence was HQI >HGWD > BHD > SFI = SMI.Conclusion All five TCMs are effective neuroprotective agents against OIPN.Among these TCMs,HQI and HGWD were superior to others in clinical efficacy.Moreover,Astragalus membranaceus might be a more promising herb for the OIPN prevention.However,more direct head-to-head RCTs with high quality and large sample size are still needed to further confirm the conclusion.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [21] Preventives for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients
    Hines, Robert Brooks
    Schoborg, Christopher
    Zhu, Xiang
    Elgin, Elizabeth
    Zhang, Shunpu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [22] Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy A protocol for Bayesian network meta-analysis
    Liu, Shilin
    Li, Andong
    Jiang, Bin
    Mi, Jia
    Nan, Hongmei
    Bao, Pengjie
    Nan, Zheng
    MEDICINE, 2022, 101 (19) : E29152
  • [23] Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action
    Alberti, Paola
    Semperboni, Sara
    Malacrida, Alessio
    Canta, Annalisa
    Chiorazzi, Alessia
    Pozzi, Eleonora
    Cavaletti, Guido Angelo
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 488 - 489
  • [24] Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
    Wang, Wei-Shu
    Lin, Jen-Kou
    Lin, Tzu-Chen
    Chen, Wei-Shone
    Jiang, Jeng-Kae
    Wang, Huann-Sheng
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Yen, Chueh-Chuan
    Chen, Po-Min
    ONCOLOGIST, 2007, 12 (03): : 312 - 319
  • [25] Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
    Jiang, Li
    Wang, Shidong
    Zhao, Jinxi
    Chien, Chieh
    Zhang, Yaofu
    Su, Guanxun
    Chen, Xiaoyu
    Song, Dechao
    Chen, Yu
    Huang, Weijun
    Xiao, Yonghua
    Cao, Yandong
    Hu, Zixian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Efficacy of traditional Chinese medicine external therapy on sleep quality in patients with cancer: A systematic review and network meta-analysis
    Bi, Liuna
    Gao, Wenjuan
    Zhang, Xian
    Li, Na
    Han, Jing
    Shi, Ming
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2023, 10 (11)
  • [27] A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
    Sina Vatandoust
    Rohit Joshi
    Kenneth B. Pittman
    Adrian Esterman
    Vy Broadbridge
    Jacqueline Adams
    Nimit Singhal
    Susan Yeend
    Timothy Jay Price
    Supportive Care in Cancer, 2014, 22 : 513 - 518
  • [28] A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
    Vatandoust, Sina
    Joshi, Rohit
    Pittman, Kenneth B.
    Esterman, Adrian
    Broadbridge, Vy
    Adams, Jacqueline
    Singhal, Nimit
    Yeend, Susan
    Price, Timothy Jay
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 513 - 518
  • [29] Predictors of oxaliplatin-induced peripheral neuropathy in patients with advanced colorectal cancer (CRC).
    Lin, A. Y.
    Kouzminova, N. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [30] Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
    Kono, Toru
    Mamiya, Noriaki
    Chisato, Naoyuki
    Ebisawa, Yosiaki
    Yamazaki, Hirotaka
    Watari, Jiro
    Yamamoto, Yasuhiro
    Suzuki, Shigetaka
    Asama, Toshiyuki
    Kamiya, Kazunori
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 8